参考文献
[1]
JemalA, BrayF, CenterMM，et al.
Global cancer statistics[J]．
CACancer JClin，
2011，
61(
2)：
69-
90.
.
[2]
WeiWI, ShamJST.
Nasopharyngeal carcinoma[J]．
Lancet，
2005，
365(
9476)：
2041-
2054.
.
[3]
LaiSZ, LiWF, ChenL，et al.
How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients？[J]．
Int J Radiat OncolBiolPhys，
2011，
80(
3)：
661-
668.
.
[4]
LeungTW, TungSY, SzeWK，et al.
Treatment results of 1070 patients with nasopharyngeal carcinoma：an analysis of survival and failure patterns[J]．
HeadNeck，
2005，
27(
7)：
555-
565.
.
[5]
LeeAWM, SzeWM, AuJSK，et al.
Treatment results for nasopharyngeal carcinoma in the modern era：the Hong Kong experience[J]．
Int JRadiat OncolBiolPhys，
2005，
61(
4)：
1107-
1116.
.
[6]
LeeAWM, PoonYF, FooW，et al.
Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985：overall survival and patterns of failure[J]．
Int J Radiat OncolBiolPhys，
1992，
23(
2)：
261-
270.
.
[7]
NgWT, LeeMCH, ChangATY，et al.
The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT[J]．
Oral Oncol，
2014，
50(
5)：
506-
512.
.
[8]
ZongJF, LinSJ, LinJ，et al.
Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma：validation of the 7th edition AJCC staging system[J]．
Oral Oncol，
2015，
51(
3)：
254-
259.
.
[9]
SunXM, SuSF, ChenCY，et al.
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma：an analysis of survival and treatment toxicities[J]．
RadiotherOncol，
2014，
110(
3)：
398-
403.
.
[10]
LiuWX, TangY, GaoL，et al.
Nasopharyngeal carcinoma in children and adolescents-a single institution experience of 158 patients[J]．
RadiatOncol，
2014，
9：
274.
.
[11]
YiJL, HuangXD, GaoL，et al.
Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma[J]．
RadiatOncol，
2014，
9：
56.
.
[12]
StokerSD, Van DiessenJNA, De BoerJP，et al.
Current treatment options for local residual nasopharyngeal carcinoma[J]．
Curr Treat Options Oncol，
2013，
14(
4)：
475-
491.
.
[13]
LuJJ, CooperJS, LeeAWM.
Nasopharyngeal carcinoma：multidisciplinary management[M]．
Berlin，Heidelberg：
Springer，
2010.
[14]
LiJX, LuTX, HuangY，et al.
Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area[J]．
SciWorldJ，
2012，
2012：
719754.
.
[15]
LeeAWM, FooW, LawSCK，et al.
Recurrent nasopharyngeal carcinoma：the puzzles of long latency[J]．
Int J Radiat OncolBiolPhys，
1999，
44(
1)：
149-
156.
.
[16]
LiJX, HuangSM, JiangXH，et al.
Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy[J]．
RadiatOncol，
2014，
9：
87.
.
[17]
KongFF, YingHM, DuCR，et al.
Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma[J]．
RadiatOncol，
2014，
9：
60.
.
[18]
邸小青，胡新荣．
鼻咽癌放疗后复发的分子机理研究进展[J]．
西南军医，
2009，
11(
5)：
936-
939.
.
DiXQ, HuXR. Research progress on the molecular mechanism of recurrence after radiotherapy for nasopharyngeal carcinoma[J]．J Mili Surg South Chin，2009，11(5)：936-939..
[19]
HongB, LuiVWY, HashiguchiM，et al.
Targeting tumor hypoxia in nasopharyngeal carcinoma[J]．
Head Neck，
2013，
35(
1)：
133-
145.
.
[20]
NichollsJ, ShamJ, NgMH，et al.
In-situ carcinoma adjacent to recurrent nasopharyngeal carcinoma：evidence of a new growth？[J]．
PatholRes Pract，
1993，
189(
9)：
1067-
1070.
.
[21]
ChanJKC, BrayF, McCarronP，et al.
Tumours of the nasopharynx[A]//
BamesL，EvesonJW，ReichartP，et al.
Pathology and GeneticsofHead and Neck Tumours：World Heath Organization Classification of Turmours[M]．
Lyon：
IARC，
2005.
[22]
NgSH, WanYL, KoSF，et al.
MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy[J]．
J Magn Reson Imaging，
1998，
8(
2)：
327-
336.
.
[23]
ZhouHJ, ShenGH, ZhangWJ，et al.
18F-FDG PET/CT for the diagnosis of residual or recurrent nasopharyngeal carcinoma after radiotherapy：a metaanalysis[J]．
JNucl Med，
2016，
57(
3)：
342-
347.
.
[24]
ComorettoM, BalestreriL, BorsattiE，et al.
Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy：comparison of MR imaging and FDG PET/CT[J]．
Radiology，
2008，
249(
1)：
203-
211.
.
[25]
YenRF, YenMF, HongRL，et al.
The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma[J]．
AcadRadiol，
2009，
16(
1)：
54-
60.
.
[26]
TianYM, ZhaoC, GuoY，et al.
Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy：a phase 2，single-center，randomized controlled trial[J]．
Cancer，
2014，
120(
22)：
3502-
3509.
.
[27]
HanF, ZhaoC, HuangSM，et al.
Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy[J]．
ClinOncol，
2012，
24(
8)：
569-
576.
.
[28]
HuaYJ, HanF, LuLX，et al.
Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy[J]．
Eur J Cancer，
2012，
48(
18)：
3422-
3428.
.
[29]
YouR, ZouX, HuaYJ，et al.
Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma-A case-matched comparison[J]．
RadiotherOncol，
2015，
115(
3)：
399-
406.
.
[30]
TianYM, GuanY, XiaoWW，et al.
Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma[J]．
HeadNeck，
2016，
38(
2)：
225-
231.
.
[31]
KongL, WangL, ShenCY，et al.
Salvage intensity-modulated radiation therapy (IMRT) for locally recurrent nasopharyngeal cancer after definitive IMRT：a novel scenario of the modern era[J]．
SciRep，
2016，
6：
32883.
.
[32]
TianYM, HuangWZ, YuanX，et al.
The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma：the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy[J]．
Oncotarget，
2017，
8(
26)：
43450-
43457.
.
[33]
ChanOSH, SzeHCK, LeeMCH，et al.
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma[J]．
Head Neck，
2017，
39(
3)：
533-
540.
.
[34]
LeeAWM, FooW, LawSCK，et al.
Reirradiation for recurrent nasopharyngeal carcinoma：factors affecting the therapeutic ratio and ways for improvement[J]．
Int J Radiat OncolBiolPhys，
1997，
38(
1)：
43-
52.
.
[35]
WangCC.
Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results[J]．
Int J Radiat OncolBiolPhys，
1987，
13(
7)：
953-
956.
.
[36]
SpencerSA, HarrisJ, WheelerRH，et al.
Final report of RTOG 9610，a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck[J]．
HeadNeck，
2008，
30(
3)：
281-
288.
.
[37]
LangerCJ, HarrisJ, HorwitzEM，et al.
Phase Ⅱ study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck：results of Radiation Therapy Oncology Group Protocol 9911[J]．
J Clin Oncol，
2007，
25(
30)：
4800-
4805.
.
[38]
LeeVHF, KwongDLW, LeungTW，et al.
Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma[J]．
EurArchOtoRhinoLaryngol，
2017，
274(
2)：
1067-
1078.
.
[39]
KaramI, HuangSH, McNivenA，et al.
Outcomes after reirradiation for recurrent nasopharyngeal carcinoma：North American experience[J]．
HeadNeck，
2016，
38(
S1)：
E1102-
E1109.
.
[40]
ChuaDTT, WuSX, LeeV，et al.
Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma：a matched-cohort analysis[J]．
Head Neck Oncol，
2009，
1：
13.
.
[41]
WuSX, ChuaDTT, DengML，et al.
Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma[J]．
Int J RadiatOncolBiolPhys，
2007，
69(
3)：
761-
769.
.
[42]
AhnYC, LeeKC, KimDY，et al.
Fractionated stereotactic radiation therapy for extracranial head and neck tumors[J]．
Int J Radiat OncolBiolPhys，
2000，
48(
2)：
501-
505.
.
[43]
OrecchiaR, ReddaMGR, RagonaR，et al.
Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinomas[J]．
RadiotherOncol，
1999，
53(
1)：
23-
28.
.
[44]
LawSCK, LamWK, NgMF，et al.
Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy：an effective means of local salvage[J]．
Int J Radiat OncolBiolPhys，
2002，
54(
4)：
1095-
1113.
.
[45]
KwongDLW, WeiWI, ChengACK，et al.
Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma[J]．
Cancer，
2001，
91(
6)：
1105-
1113.
.
[46]
LeungTW, TungSY, SzeWK，et al.
Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma[J]．
Int J Radiat OncolBiolPhysi，
2000，
48(
5)：
1331-
1338.
.
[47]
RomesserPB, CahlonO, ScherED，et al.
Proton beam reirradiation for recurrent head and neck cancer：multi-institutional report on feasibility and early outcomes[J]．
Int J Radiat OncolBiolPhys，
2016，
95(
1)：
386-
395.
.
[48]
KongL, HuJY, GuanXY，et al.
Phase Ⅰ/Ⅱ trial evaluating carbon ion radiotherapy for salvaging treatment of locally recurrent nasopharyngeal carcinoma[J]．
J Cancer，
2016，
7(
7)：
774-
783.
.
[49]
FeeWE, MoirMS, ChoiEC，et al.
Nasopharyngectomy for recurrent nasopharyngeal cancer：a 2-to 17-year follow-up[J]．
Arch OtolaryngolHead Neck Surg，
2002，
128(
3)：
280-
284.
.
[50]
WeiWL, LamKHL, ShamJST.
New approach to the nasopharynx：the maxillary swing approach[J]．
HeadNeck，
1991，
13(
3)：
200-
207.
.
[51]
KingWWK, KuPKM, MokCO，et al.
Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma：a twelve-year experience[J]．
HeadNeck，
2000，
22(
3)：
215-
222.
.
[52]
HsuMM, HongRL, TingLL，et al.
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site：experience with 60 cases[J]．
Arch OtolaryngolHead Neck Surg，
2001，
127(
7)：
798-
802.
[53]
Na′araS, AmitM, BillanS，et al.
Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma：a meta-analysis[J]．
Ann Surg Oncol，
2014，
21(
9)：
3056-
3062.
.
[54]
VlantisAC, ChanHS, TongMCF，et al.
Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma：a multivariate analysis of prognostic factors[J]．
Head Neck，
2011，
33(
8)：
1126-
1131.
.
[55]
ChanYW, ChowVLY, WeiWI.
Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma[J]．
Cancer，
2012，
118(
15)：
3710-
3718.
.
[56]
ChenMK, LaiJC, ChangCC，et al.
Minimally invasive endoscopic nasopharyngectomy in the treatment of recurrent T1-2 a nasopharyngeal carcinoma[J]．
Laryngoscope，
2007，
117(
5)：
894-
896.
.
[57]
YoshizakiT, WakisakaN, MuronoS，et al.
Endoscopic nasopharyngectomy for patients with recurrent nasopharyngeal carcinoma at the primary site[J]．
Laryngoscope，
2005，
115(
8)：
1517-
1519.
.
[58]
LiuJ, YuHP, SunXC，et al.
Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma：a 10-year experience[J]．
Int J Clin Oncol，
2017，
22(
5)：
834-
842.
.
[59]
YouR, ZouX, WangSL，et al.
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system[J]．
Eur J Cancer，
2015，
51(
13)：
1771-
1779.
.
[60]
ChanJYW, WeiWI.
Three-dimensional endoscopy for endoscopic salvage nasopharyngectomy：Preliminary report of experience[J]．
Laryngoscope，
2017.
.
[61]
MaiHQ, MoHY, DengJF，et al.
Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma[J]．
Eur J Cancer，
2009，
45(
7)：
1107-
1110.
.
[62]
ShamJST, ChoyD．
Nasopharyngeal carcinoma：treatment of neck node recurrence by radiotherapy[J]．
Australas Radiol，
1991，
35(
4)：
370-
373.
.
[63]
ZhangL, ZhuYX, WangY，et al.
Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma：a 10-year experience[J]．
Ann Surg Oncol，
2011，
18(
1)：
233-
238.
.
[64]
张纲，李彩，刘磊，等．
鼻咽癌放疗后颈淋巴结残留/复发的手术治疗分析[J]．
肿瘤，
2002，
22(
6)：
514-
515.
.
ZhangG, LiC, LiuL，et al. Surgical treatment of cervical lymph node residual/recurrence after radiotherapy of nasopharyngeal carcinoma[J]．Tomor，2002，22(6)：514-515..
[65]
徐震纲，屠规益，唐平章．
鼻咽癌放射治疗失败后的手术治疗[J]．
中华耳鼻咽喉科杂志，
1998，
33(
2)：
103-
105.
.
XuZG, TuGY, TangPZ. Surgical treatment after the failure of radiotherapy for nasopharyngeal carcinoma[J]．Chin J Otolaryngol，1998，33(2)：103-105..
[66]
闵华庆，张锋，张锦明．
放疗后复发鼻咽癌的手术治疗[J]．
癌症，
1989，
8(
5)：
365-
367.
MinHQ, ZhangF, ZhangJM.Surgical treatment of recurrent nasopharyngeal carcinoma after radiotherapy[J]．Chin J Cancer，1989，8(5)：365-367.
[67]
LoWC, WangCP, KoJY，et al.
Salvage treatment for isolated regional failure of nasopharyngeal carcinoma after primary radiotherapy[J]．
Ann Surg Oncol，
2012，
19(
3)：
1001-
1018.
.
[68]
ZhangL, HuangY, HongSD，et al.
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma：a multicentre，randomised，open-label，phase 3 trial[J]．
Lancet，
2016，
388(
10054)：
1883-
1892.
.
[69]
GuanY, LiuS, WangHY，et al.
Long-term outcomes of a phase Ⅱ randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma[J]．
Chin J Cancer，
2016，
35：
20.
.
[70]
ChanATC, HsuMM, GohBC，et al.
Multicenter，phase Ⅱ study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma[J]．
J Clin Oncol，
2005，
23(
15)：
3568-
3576.
.
[71]
HsuC, LeeSH, EjadiS，et al.
Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma：results of the KEYNOTE-028 study[J]．
J Clin Oncol，
2017.
.
